Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06531486
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-05-28
Brief Title:
A Study of XS-02 Capsules in Patients With Advanced Solid Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Open Label Single-arm Phase III Dose-escalation and Dose-expansion Study to Evaluate the Safety Tolerability Pharmacokinetic Profile and Initial Efficacy of XS-02 Capsules in Patients With Advanced Solid Tumors
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to evaluate the safety tolerability Pharmacokineticspk and efficacy of XS-02 capsules in patients with advanced solid tumors
Detailed Description:
This is a multicenter open label single-arm Phase III dose-escalation and dose-expansion study to evaluate the safety tolerability pharmacokinetic profile and initial efficacy of XS-02 capsules in patients with advanced solid tumors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None